文章詳目資料

台灣泌尿科醫學會雜誌

  • 加入收藏
  • 下載文章
篇名 Robotic-assisted Laparoscopic Radical Prostatectomy: Current Status and Single Surgeon Experience in Taichung Veterans General Hospital
卷期 19:1
作者 Ou, Yen-chuanYang, Chi-reiCheng, Chen-li
頁次 040-045
關鍵字 LaparoscopyProstate cancerRadical prostatectomyRobotics
出刊日期 200803

中文摘要

英文摘要

Background and Purpose/Objectives: We reviewed current status of robotic-assisted laparoscopic radical prostatectomy (RALP) internationally and shared our personal experience with this procedure. Methods: We compared our initial 30 cases with first Menon's publication paper of 30 cases receiving RALP. We reviewed RALP literature published between 1998 and August 2007. Preoperative clinical characteristics were collected, including age, PSA, biopsy Gleason score, and clinical stage. Surgical factors were analyzed, including estimated blood loss, transfusion rate, operation time, complications and conversion rate. Clinical outcomes were compared, including hospital stay, length of Foley catheterization, positive margin rate, continence rate, potency rate and biochemical failure rate. Results: The surgeon's skill became stable with console time of 166.5 minutes and vesicourethral anastomosis time of 39.5 minutes, at a learning curve of about 30 cases. In the literature review, current status of RALP included a mean operative time from 130 to 540 minutes; mean estimated blood loss in various series of 75 to 900 ml.; transfusion rate from 0 to 16.6%, and average hospital stay only 1.08 to 5.5 days. Continence was 25 to 42% after robotic radical prostatectomy with immediate continence rate determined just after catheter removal. More than 92% continence had been regained at one year. Best preservation of sexual function was shown by Athermal Robotic Technique. Largest series was reported by Menon et al. showing an actual biochemical recurrence rate of 2.3% at median 36 months. Conclusion: Initial experience of 30 RALPs in Taiwan confirms a learning curve of about 30 cases for basic technique of RALP with acceptable operation time. Excellent outcomes are achieved for early-stage prostate cancer (T1c, lower PSA, lower Gleason score) receiving RALP. Erectile function and oncological results need additional data on long-term follow-up.

相關文獻